Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 233

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 233
---
in thousands)                               |     | Current 
 Portion |     | Long Term |
| Repayment of Clearwater’s existing term loan |     |         |     |           |
| Issuance of new debt:                        |     |         |     |           |
| Borrowings under the 2025 Term Loan          |     |         |     |           |
| Debt issuance costs                          |     |         |     |           |
| Pro forma adjustments                        |     |         |     |           |

| B. | Interest Expense |

Represents an increase in interest expense of $ million for the year ended December 31, 2024, which includes the interest on the $800 million principal borrowings under the 2025 Term Loan, calculated using the effective interest rate method, with a weighted average annual interest rate of %, less the interest expense of $ million on the existing term loan that is assumed to be repaid as of January 1, 2024. 154

COMPARISON OF RIGHTS OF COMMON STOCKHOLDERS OF CLEARWATER AND ENFUSION Clearwater and Enfusion are both incorporated under the laws of the state of Delaware. If the Transactions are completed, the rights of Enfusion Stockholders who become Clearwater Stockholders will be, and the rights of Clearwater Stockholders will continue to be, governed by the DGCL, the Amended and Restated Certificate of Incorporation of Clearwater (the “ Clearwater Charter”) and the Amended and Restated Bylaws of Clearwater (the “ Clearwater Bylaws”). The following is a summary of the material differences between (i) the current rights of Clearwater Stockholders under the Clearwater Charter and the Clearwater Bylaws and (ii) the current rights of Enfusion Stockholders under the Amended and Restated Certificate of Incorporation of Enfusion (the “ Enfusion Charter”) and the Amended and Restated Bylaws of Enfusion (the “ Enfusion Bylaws”). The following summary is not a complete description of the specific provisions referred to below. The summary is qualified in its entirety by reference to Clearwater’s and Enfusion’s respective governing documents, which we urge you to read carefully and in their entirety. Copies of the Clearwater Charter, the Clearwater Bylaws, the Enfusion Charter and the Enfusion Bylaws have been filed with the SEC and are available, without charge, to any person, including any beneficial owner to whom this document is delivered, by following the instructions in the section titled